emtricitabine has been researched along with Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Beumer, JH; Chaphekar, N; Chu, E; Guo, J; Jones, R; Joshi, A; Kiesel, BF; Kunos, CA; Taylor, S; Venkataramanan, R | 1 |
1 other study(ies) available for emtricitabine and Neoplasms
Article | Year |
---|---|
In vitro evaluation of the metabolic enzymes and drug interaction potential of triapine.
Topics: Cells, Cultured; Chemoradiotherapy; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inducers; Drug Evaluation, Preclinical; Drug Interactions; Emtricitabine; Hepatocytes; Humans; Inactivation, Metabolic; Microsomes, Liver; Neoplasms; Primary Cell Culture; Pyridines; Radiation-Sensitizing Agents; Tandem Mass Spectrometry; Tenofovir; Thiosemicarbazones | 2020 |